Array
(
[0] => stdClass Object
(
[id] => 1380
[id_crawler] =>
[category_product] => NULL
[thumbnail] => 583886482_1245783690902579_3797177799609396580_n.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 1
[displayed_time] => 2025-11-18
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2025-11-18 10:48:14
[updated_time] => 2025-11-18 10:51:36
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 0
[language_code] => en
[slug] => Genetics-in-assisted-reproduction-breakthroughs-bringing-new-hope-to-infertile-couples
[title] => Genetics in assisted reproduction – breakthroughs bringing new hope to infertile couples
[description] => Over the years, infertility has become one of the major concerns of modern medicine. Statistics show that as many as 12.6% of couples worldwide face difficulties in conceiving. The causes may stem from the husband, the wife, both partners, or in some cases cannot be clearly identified. However, alongside advances in assisted reproductive technologies (ART), particularly the groundbreaking applications of genetics, the journey to parenthood for infertile couples is now more hopeful than ever.
[content] => From fundamental techniques such as in vitro fertilization, medicine has continuously achieved remarkable progress. One of the most significant milestones is the application of genetics in assisted reproduction—allowing doctors not only to create embryos but also to select the healthiest ones, thereby increasing the chances of success.

According to Assoc. Prof. Dr. Trinh The Son – Director of the Military Clinical Embryology Institute, Vietnam Military Medical Academy – genetics now plays a pivotal role in the field of assisted reproduction. Through genetic and chromosomal analyses, doctors can identify the root causes of infertility at the deepest biological levels, detecting chromosomal abnormalities such as Klinefelter syndrome, Turner syndrome, or AZF microdeletions in men, as well as gene mutations that may lead to vas deferens obstruction or premature ovarian failure. More importantly, genetic information enables personalized treatment regimens tailored to each patient’s genetic characteristics.
One of the most prominent achievements in this field is preimplantation genetic testing (PGT). This technique allows doctors to select embryos with normal chromosomal makeup and eliminate those carrying abnormalities that may lead to miscarriage or genetic disorders. PGT includes several types such as PGT-A, PGT-M, and PGT-SR. PGT-A helps detect abnormalities in chromosome numbers, such as Down syndrome; PGT-M is used for couples carrying genetic diseases like Thalassemia or cystic fibrosis to ensure only embryos without the disease-causing gene are transferred; while PGT-SR helps detect structural chromosomal abnormalities such as translocations or inversions, proving particularly valuable in cases of recurrent miscarriage or unexplained infertility.
Beyond these, scientists are researching and applying non-invasive screening methods, notably niPGT – a technique analyzing cell-free DNA in embryo culture media, eliminating the need for embryo biopsy and improving embryo safety during development.
In addition, the emergence of advanced tests such as PGT NEXT, PGT UPGRADE, WES, and WGS is significantly improving success rates in assisted reproduction. PGT NEXT enables comprehensive chromosomal assessment of embryos, detecting aneuploidy, mono- and polyploidy, as well as structural abnormalities, while using SNP analysis to prevent sample mix-ups and accurately identify healthy diploid embryos. PGT UPGRADE goes a step further by detecting embryos carrying balanced translocations inherited from parents—a common cause of recurrent miscarriage—allowing doctors to select embryos without such abnormalities and improving the chances of a healthy pregnancy for couples with chromosomal translocations.

Meanwhile, WES (whole exome sequencing) and WGS (whole genome sequencing) open the door to identifying rare, complex, or previously unknown mutations related to infertility. WES examines more than 22,000 coding genes—where most disease-causing variants are concentrated—while WGS provides the most comprehensive genomic overview, helping doctors uncover deep-seated causes in difficult cases, thereby personalizing treatment plans and optimizing patient success rates.

Artificial intelligence and big data analytics are also becoming powerful tools for selecting embryos with the highest developmental potential. AI systems can analyze thousands of data points on embryo morphology and development speed to suggest the healthiest embryo, significantly increasing success rates for infertile couples.
Genetics not only enhances the effectiveness of infertility treatment but also aims toward selecting healthy embryos, ensuring precise treatment, and preventing genetic diseases. Assoc. Prof. Dr. Trinh The Son emphasizes that it is essential to approach these technologies with humanity and responsibility so that science truly serves human happiness.
On the journey toward parenthood, each advancement in genetic medicine is a beacon of hope—illuminating the dreams of millions of infertile families and bringing them closer to the “miracle of life.”
[content_more] =>
[meta_title] => Genetics in assisted reproduction – breakthroughs bringing new hope to infertile couples
[meta_description] => Over the years, infertility has become one of the major concerns of modern medicine. Statistics show that as many as 12.6% of couples worldwide face difficulties in conceiving.
[meta_keyword] => GENTIS,PGT,WES,WGS
[thumbnail_alt] =>
[post_id] => 1380
[category_id] => 14
)
[1] => stdClass Object
(
[id] => 1379
[id_crawler] =>
[category_product] => NULL
[thumbnail] => hoi-nghi-khoa-hoc-hosrem-lan-thu-20.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2025-11-17
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2025-11-17 14:25:06
[updated_time] => 2025-11-21 10:09:07
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => Eurofins-GENTIS-accompanies-the-20th-annual-HOSREM-scientific-conference
[title] => Eurofins GENTIS accompanies the 20th annual HOSREM scientific conference
[description] => On November 23, 2025, the 20th Annual HOSREM Scientific Conference will officially take place at the Equatorial Hotel in Ho Chi Minh City, marking an important milestone for one of the most prestigious scientific forums in the fields of obstetrics–gynecology and reproductive health in Vietnam. This year, Eurofins GENTIS is honored to join the conference as the main sponsor, offering a wide range of professional activities and meaningful interactions for attending delegates.
[content] => HOSREM – 20 Years of Knowledge Building and Expert Connection
The HOSREM Annual Scientific Conference is a reputable forum in obstetrics–gynecology and reproductive health, where the latest knowledge and advances are shared by leading experts. Over the past 20 years, HOSREM has grown into a major scientific event, gathering numerous delegates from hospitals and medical centers across the country.
Beyond being a venue for updating specialized knowledge, HOSREM serves as a bridge connecting scientific research, clinical experience, and practical applications in reproductive healthcare. Throughout its 20 editions, HOSREM has consistently remained a trusted platform for academic exchange and for sharing the latest medical advancements. It also promotes collaboration among hospitals, medical centers, and research institutes both domestically and internationally. In addition, HOSREM inspires innovation and encourages the integration of technology into reproductive healthcare in Vietnam.
This year's conference continues to bring together leading experts from major hospitals, reproductive centers, laboratories, and healthcare organizations nationwide, offering a comprehensive and in-depth picture of the current landscape in obstetrics and gynecology.

2025 Conference Themes: Addressing Key Issues in Clinical Practice
The 20th HOSREM Conference will focus on practical and highly relevant topics in obstetrics, gynecology, and assisted reproduction. This year’s program highlights common and critical issues in clinical practice, featuring engaging presentations by seasoned experts and physicians, promising valuable updates and insights for all attendees.
A major highlight of this year’s event is the participation of top Vietnamese specialists in IVF, fetal medicine, medical genetics, and reproductive healthcare. They will present up-to-date research findings, unique clinical cases, and emerging trends that help improve treatment outcomes.
In addition to scientific presentations, open discussion sessions will offer delegates the opportunity to exchange experiences, share clinical challenges, and explore feasible solutions for patients in today’s context.
Eurofins GENTIS – Partnering with HOSREM for a future of comprehensive reproductive health
With the mission “Enhancing the Physical and Intellectual Well-being of Vietnamese People,” Eurofins GENTIS joins HOSREM 2025 as a main sponsor, bringing advanced genetic solutions that support obstetrics and assisted reproduction.
Over the years, Eurofins GENTIS has continuously improved testing quality by adopting cutting-edge technologies from Eurofins Scientific—one of the world’s largest laboratory groups. GENTIS’s specialized genetic tests play a significant role in:
Eurofins GENTIS firmly believes that integrating genetic testing into clinical practice not only improves treatment efficacy but also gives families the chance to welcome healthy babies while reducing risks and healthcare burdens.
At this year’s conference, the Eurofins GENTIS booth is designed to provide a friendly and modern space where delegates can:
We believe that the development of obstetrics, gynecology, and assisted reproduction cannot be separated from the advancement of genetic testing technologies. Our continued partnership with HOSREM reflects GENTIS’s commitment to contributing to shared goals:
As the demand for reproductive healthcare grows, the integration of genomics into clinical practice becomes essential to ensure optimal treatment outcomes and improve population health.
The 20th Annual HOSREM Scientific Conference promises to be a knowledge-rich, inspiring event that fosters meaningful collaborations among medical institutions, hospitals, reproductive centers, and laboratories nationwide.
Eurofins GENTIS warmly invites all delegates to visit our booth for professional exchange, information sharing, and hands-on experience with the most advanced genetic solutions available today.
We look forward to welcoming you at HOSREM 2025—where knowledge converges, connections flourish, and innovation begins!
[content_more] => [meta_title] => Eurofins GENTIS accompanies the 20th annual HOSREM scientific conference [meta_description] => On November 23, 2025, the 20th Annual HOSREM Scientific Conference will officially take place at the Equatorial Hotel in Ho Chi Minh City, marking an important milestone for one of the most prestigious scientific forums in the fields of obstetrics–gynecol [meta_keyword] => GENTIS,HOSREM [thumbnail_alt] => [post_id] => 1379 [category_id] => 14 ) [2] => stdClass Object ( [id] => 1378 [id_crawler] => [category_product] => NULL [thumbnail] => 48be86a032fdbea3e7ec.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-11-03 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-11-03 10:24:41 [updated_time] => 2025-11-21 10:13:42 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-accompanies-the-25th-Vietnam-France-obstetrics-and-gynecology-conference-2025 [title] => Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025) [description] => Amid the dynamic collaboration between Vietnam and France in the field of medicine, the 25th Vietnam–France Obstetrics and Gynecology Conference will officially take place on November 9–10, 2025, in Hanoi. This prestigious annual scientific event in obstetrics and gynecology is hosted by the National Hospital of Obstetrics and Gynecology (NHOG) in collaboration with the French National College of Gynecologists and Obstetricians (CNGOF). [content] =>This year’s conference marks 25 years of effective cooperation between the two nations in training, research, and the transfer of medical advances—aiming to improve reproductive healthcare quality and contribute to the protection and development of the Vietnamese population.
With 1,500 delegates attending onsite and another 1,000 participating online, the conference gathers leading scientists, physicians, and specialists from Vietnam, France, and many other countries. It serves as an important academic platform for experts to exchange and update the latest knowledge in obstetrics, gynecology, assisted reproduction, and medical genetics.
With the mission “Enhancing the Intellectual and Physical Well-being of Vietnamese People,” Eurofins GENTIS is honored to accompany the 25th Vietnam–France Obstetrics and Gynecology Conference as a sponsor. Our presence at the event reflects not only our spirit of cooperation and commitment to the medical community but also our dedication to promoting the scientific value and practical application of genetic testing in reproductive healthcare.
Over the past 15 years, Eurofins GENTIS has become a pioneer in genetic testing in Vietnam, operating a network of laboratories accredited by CAP and ISO 15189:2022, and supported by leading domestic and international scientific advisors. GENTIS provides genetic testing services that serve individuals and families while also supporting obstetricians and gynecologists in diagnosis, pregnancy monitoring, and the management of reproductive health issues.

At this year’s Vietnam–France Obstetrics and Gynecology Conference, Eurofins GENTIS introduces an exhibition and consultation booth where delegates can explore comprehensive genetic testing solutions.
Featured services include:
In addition to showcasing technologies and services, the GENTIS team will be present to answer questions and offer expert consultation to physicians, researchers, and attendees. The Eurofins GENTIS booth is designed with a modern, open layout, creating a friendly and effective space for discussion.
To bring a more engaging and interactive experience to delegates, Eurofins GENTIS is hosting an interactive minigame at our booth throughout the conference.
With simple participation steps, visitors can join quick interactive activities or answer questions related to genetics and reproductive health to receive meaningful and surprising gifts from GENTIS.
Beyond entertainment, the minigame serves as a bridge to help physicians, scientists, and guests better understand the vital role of genetics in modern medicine—from prenatal screening and assisted reproduction to community genetic counseling.
Through these approachable activities, GENTIS aims to spread the message:
“Genetics is not distant—it is a companion in every family’s reproductive healthcare journey.”
In recent years, cooperation between Vietnam and France in obstetrics and gynecology has achieved remarkable progress. The conference is not only a platform for academic exchange but also a venue for connecting institutions, hospitals, enterprises, and research centers to promote the application of advanced science in clinical practice.
GENTIS is proud to be part of this journey. By continuously investing in technology, enhancing professional quality, and expanding international cooperation, we aim to bring advanced genetic testing closer to Vietnamese people and support healthcare professionals in diagnosing, treating, and preventing genetic diseases.
With core values of “Integrity, Innovation, Dedication, Respect, and Continuous Learning,” Eurofins GENTIS has become a trusted partner of hundreds of hospitals, IVF centers, and healthcare institutions nationwide. Our products, services, and research initiatives are designed to enhance population health, support safe and effective reproduction, and align with Vietnam’s comprehensive healthcare orientation.
Our sponsorship of the 2025 Vietnam–France Obstetrics and Gynecology Conference demonstrates our commitment to sharing knowledge, creating value, and contributing to the modernization of Vietnamese medicine toward international standards.
The 25th Vietnam–France Obstetrics and Gynecology Conference promises to be one of the most significant scientific events of 2025, opening new directions in research, collaboration, and application in reproductive healthcare.
Eurofins GENTIS warmly invites physicians, specialists, and delegates to visit the GENTIS booth to explore advanced genetic solutions, update new trends, and participate in our exciting minigame for a chance to receive special gifts.
[content_more] => [meta_title] => Eurofins GENTIS accompanies the 25th Vietnam–France obstetrics and gynecology conference (2025) [meta_description] => Amid the dynamic collaboration between Vietnam and France in the field of medicine, the 25th Vietnam–France Obstetrics and Gynecology Conference will officially take place on November 9–10, 2025, in Hanoi. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1378 [category_id] => 14 ) [3] => stdClass Object ( [id] => 1377 [id_crawler] => [category_product] => NULL [thumbnail] => a726c71514489816c159.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-11-03 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-11-03 10:17:32 [updated_time] => 2025-11-21 10:22:11 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-welcomes-the-delegation-from-Orienda-international-hospital [title] => GENTIS welcomes the delegation from Orienda International hospital [description] => On November 1, 2025, Eurofins GENTIS had the honor of welcoming a delegation from Orienda International Hospital (Phnom Penh, Cambodia) to visit and work at the company headquarters. The visit was part of an international cooperation program designed to enhance professional exchange, share experiences, and expand development opportunities in reproductive medicine and laboratory testing between the two organizations. [content] =>The delegation from Orienda International Hospital included Mr. Leangseng – Head of Laboratory Department and Dr. Chhit Maryan. Representing Eurofins GENTIS were Mr. Nguyen Van Huynh – R&D Team Leader, Dr. Vu Thu Huong – R&D Specialist, and Ms. Le Thi Thuy Hang – International Cooperation Coordinator.
The working session took place in an open, warm, yet professional atmosphere, reflecting the shared mission of both organizations: to elevate the quality of reproductive healthcare in Southeast Asia.

Orienda International Hospital is one of the leading private hospitals in Phnom Penh, Cambodia, built to international standards with a total investment of over 20 million USD. Developed as a multidisciplinary international hospital, Orienda emphasizes not only medical expertise but also patient experience—creating a safe, modern, and patient-centered environment.
The hospital is equipped with advanced and synchronized medical infrastructure, meeting strict requirements for examination, treatment, and healthcare services. Orienda offers a wide range of medical services, including:
With a team of physicians and healthcare specialists from Cambodia, Singapore, and several other countries, Orienda aims to deliver international-standard medical services to Cambodian citizens and the international community living and working there.
As part of its development strategy, Orienda places strong emphasis on cooperation with international partners in laboratory testing and biotechnology to enhance expertise and adopt modern diagnostic technologies. Therefore, this visit to Eurofins GENTIS carries significant meaning in fostering collaboration, learning, and expanding partnership opportunities.


During the working session, the two sides engaged in in-depth discussions on reproductive laboratory technologies, including pre- and post-implantation genetic testing solutions, embryo screening techniques, and gene-based analyses supporting infertility treatment.
The GENTIS R&D team presented an overview of the company’s comprehensive genetic testing ecosystem, including several pioneering services in Vietnam and Southeast Asia such as:
Following the presentation, the Orienda delegation toured the Eurofins GENTIS laboratories, where stringent quality management procedures are implemented based on international standards of Eurofins Scientific. The Orienda experts expressed high appreciation for GENTIS’s testing capabilities, laboratory technologies, and well-trained personnel.

The working session was not only an opportunity for both sides to share expertise and experience in genetic testing, but also opened potential for strategic collaboration in the near future.
Eurofins GENTIS and Orienda International Hospital agreed to pursue common goals:
This connection is expected to lay the foundation for joint training programs, collaborative research, and technology transfer in genetic testing.
In the coming period, GENTIS and Orienda plan to continue regular professional exchanges and explore specific collaborative projects in assisted reproduction, genetic diagnostics, and workforce training. Both organizations anticipate that this cooperation will facilitate greater access to high-tech medical innovations for physicians and patients in Cambodia, while strengthening Vietnam’s position as a regional leader in medical genetics.
The working session between Eurofins GENTIS and Orienda International Hospital marks a new step forward in international collaboration and reflects GENTIS’s vision of connecting global scientific knowledge to improve human life. GENTIS remains committed to investing in research, technological advancement, and global partnerships—contributing sustainable value to the community for a healthier, happier future.
[content_more] => [meta_title] => GENTIS welcomes the delegation from Orienda International hospital [meta_description] => On November 1, 2025, Eurofins GENTIS had the honor of welcoming a delegation from Orienda International Hospital (Phnom Penh, Cambodia) to visit and work at the company headquarters. [meta_keyword] => [thumbnail_alt] => [post_id] => 1377 [category_id] => 14 ) [4] => stdClass Object ( [id] => 1376 [id_crawler] => [category_product] => NULL [thumbnail] => 600x400-web-gentis-15-nam.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-26 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:55:32 [updated_time] => 2025-10-29 10:00:15 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-15-years-sowing-aspirations-reaping-trust [title] => GENTIS 15 Years – sowing aspirations, reaping trust [description] => On October 26, 2010, a small milestone was marked in the field of biomedical science in Vietnam: GENTIS – the first genetic testing center in Hanoi – was founded. Few knew that from this modest beginning, a 15-year journey of perseverance and dedication to the mission “Enhancing the Physical and Intellectual Health of Vietnamese People” would unfold, built on trust, knowledge, and resilience to overcome every challenge. [content] =>From first steps to remarkable achievements in genetics
Starting in Hanoi with the aspiration to “pioneer the field of genetics,” GENTIS was among the first institutions in Vietnam to introduce access to genetic science – a technology largely unfamiliar to most people at that time. Driven by strong faith in the future, within just three years, GENTIS opened a branch in Ho Chi Minh City, marking the first step in bringing the world’s most advanced genetic technology closer to Vietnamese people.
In 2015, GENTIS became the first DNA laboratory in Vietnam to achieve ISO 9001:2015 certification, with its testing systems built according to the recommendations of the U.S. FBI. This was not only an achievement but a strong affirmation of GENTIS’s commitment to quality and international standards as the foundation for its development.
Continuing its growth, in 2017 GENTIS expanded into oncology and infectious disease testing. By 2018, GENTIS reached the international stage as an official partner of Illumina (USA), the world leader in gene sequencing.
From 2019 to 2020, GENTIS focused on providing genetic analysis solutions to support reproductive health and comprehensive healthcare, consistently placing people at the center of every development strategy.
In 2021, the Covid-19 pandemic posed a significant test for the healthcare sector, and GENTIS stepped up. The company became one of the few private healthcare facilities certified for SARS-CoV-2 testing, collaborating with Hanoi CDC on large-scale community testing campaigns. GENTIS staff worked tirelessly on the front lines, collecting samples and running tests, contributing to the protection of millions of people across the country.
In 2022, GENTIS officially became a member of Eurofins – the world’s leading medical group – marking a historic turning point and elevating GENTIS to an international brand. This was not just a legal merger but a complete transformation in processes, personnel, mindset, and technology.
Building on this success, in 2024 Eurofins – GENTIS inaugurated a new, modern 2,000 m² headquarters in central Hanoi, a significant step in both scale and readiness to meet the growing and increasingly complex testing needs of domestic and international clients.
GENTIS hosts CAP expert delegation to evaluate Hanoi laboratory
After more than a year of relentless effort, hundreds of strict criteria, and thousands of hours of quality inspections, in June 2025, Eurofins – GENTIS became the pioneering unit in Vietnam to achieve CAP certification for two core genetic tests: PGT and NIPT. For the first time, a genetic testing facility in Vietnam was recognized internationally at the highest level for quality and expertise in the two most advanced techniques in reproductive support and prenatal screening. This achievement was not only GENTIS’s success but also a step forward for Vietnam’s biomedical industry on the global map.
Raising the standards of Vietnamese genetic medicine
GENTIS has contributed not only to its own growth but also to the advancement of Vietnam’s biomedical sector. Deep genetic tests, which previously had to be sent abroad at high costs, can now be performed domestically with equivalent quality. As shared by Assoc. Prof. Dr. Nguyen Dinh Tao, Chairman of the Hanoi Association for Reproductive Support: “GENTIS participates in conferences, workshops, and scientific activities both in-person and online. With its professional expertise, personnel, and advanced medical equipment and technology, GENTIS has helped introduce modern genetic testing technologies in Vietnam, particularly in reproductive support.”

Prof. Tao added: “Previously, many genetic tests for reproductive support had to be done overseas at high costs. Now, units like GENTIS have applied advanced technology and equipment locally, playing a crucial role in developing Vietnam’s reproductive support sector and improving success rates. As a result, infertile couples, including overseas Vietnamese, can now return to Vietnam for reproductive support services.”
Moreover, GENTIS actively collaborates with hospitals, universities, and international organizations to bring applied scientific value closer to the Vietnamese medical community.
Linking business growth with social responsibility
Beyond professional development, GENTIS pursues community initiatives, such as:

People – the heart of every achievement
Over 15 years, equipment and technology may evolve, but the soul of GENTIS lies in its people. From resident doctors, R&D specialists, project managers, sample collectors, lab technicians, business and customer care staff, to HR, accounting, marketing, legal, ISO, and procurement teams – all are professionally trained, continuously updating their knowledge and skills.
GENTIS leadership recognizes that quality is the company’s core value, and thus has built a dedicated, loyal, and constantly improving workforce.

To nurture this internal “family,” GENTIS organizes annual events such as Year-End Party, Lunar New Year outings, annual trips, comprehensive health checkups, company birthdays, and more, fostering unity and a strong, cohesive team.
Future direction: Continuous innovation – continuous quality improvement
Regarding future development, Mr. Do Manh Ha stated that Eurofins – GENTIS has clearly defined goals:
15 years – leading and growing
Fifteen years may not be a long journey, but it has firmly placed GENTIS on Vietnam’s genetic medicine map, leaving a lasting impression on customers, partners, and the community. GENTIS is proud to have accompanied families in tracing their roots, infertile couples on their journey to parenthood, and protecting the health of future generations.
GENTIS will continue to advance with Vietnamese heart, Vietnamese intellect, and international standards, committed to constantly improving services to meet global benchmarks in genetic and genomic testing.
[content_more] => [meta_title] => GENTIS 15 Years – sowing aspirations, reaping trust [meta_description] => On October 26, 2010, a small milestone was marked in the field of biomedical science in Vietnam: GENTIS – the first genetic testing center in Hanoi – was founded. [meta_keyword] => [thumbnail_alt] => [post_id] => 1376 [category_id] => 14 ) [5] => stdClass Object ( [id] => 1375 [id_crawler] => [category_product] => NULL [thumbnail] => my205757.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2025-10-26 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:46:10 [updated_time] => 2025-10-29 09:41:21 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-15-years-of-creating-value-for-public-health [title] => GENTIS – 15 years of creating value for public health [description] => On the evening of October 25, 2025, in the beautiful coastal city of Ha Long, GENTIS Genetic Analysis Services Joint Stock Company (GENTIS) solemnly held its 15th Anniversary Celebration (October 26, 2010 – October 26, 2025) in a warm, heartfelt, and highly emotional atmosphere. [content] =>The event served as an opportunity for all employees, customers, and partners to reflect on the proud journey so far while fueling motivation to move forward toward the future with unwavering belief and ambition.
A Milestone journey – 15 years of steady progress
Since its founding in 2010, GENTIS has continuously grown and established a leading position in the field of genetic analysis in Vietnam. With a long-term vision, sustainable development strategy, and a high-quality workforce, GENTIS has become a pioneering symbol in applying genetic technology for healthcare.

Over the past 15 years, the journey has been full of effort and challenges, yet marked by remarkable achievements:
GENTIS has played an important role in modernizing Vietnamese medicine through the application of advanced genetic testing solutions for diagnosis, treatment, and disease prevention.
A warm, emotional, and memorable celebration
Held in one of the country’s most famous tourist destinations – Ha Long, the anniversary celebration was not only a milestone event but also an occasion for everyone to share, express gratitude, and connect. The ceremony began with a commemorative photo session of the leadership board, employees, and guests. The space was vibrant with colors, dazzling lights, and cheerful laughter, creating a cozy start to a grand event.

Following that, the audience enjoyed lively performances organized and performed by GENTIS members themselves. Heroic songs and graceful dances not only showcased artistic talent but also reflected the spirit of unity, creativity, and enthusiasm – hallmarks of GENTIS culture.



Highlights of the event
One of the most touching moments of the ceremony was the speech by Mr. Đo Manh Ha – CEO of GENTIS. He recounted the company’s 15-year journey of relentless effort and expressed heartfelt gratitude to all employees, partners, and customers – those who have accompanied, continue to accompany, and will accompany GENTIS in its mission to serve public health.



Mr. Đo Manh Ha also reaffirmed the company’s strategic vision for the next phase, in which GENTIS will continue to:

One of the most impressive moments was the recognition of employees with 5, 10, and 15 years of service. These are the people who have devoted themselves to building GENTIS into the strong company it is today. Each name called, each bouquet presented, each warm embrace brought happiness, pride, and a sense that their contributions are always valued.
Following the recognition ceremony was the most meaningful moment: the leadership and management team raised their glasses and cut the birthday cake, officially marking GENTIS’s 15th anniversary. The cake, designed with the GENTIS logo in hopeful green and pure white, symbolized a firm belief in the company’s bright future.
This moment was not only a summary of a remarkable journey but also the starting point for the paths ahead, where GENTIS will continue to grow, innovate, and serve the health of millions of Vietnamese people.
Looking ahead
The 15th-anniversary celebration was not only a time to reflect on the past but also a strong affirmation that GENTIS will not stop here.
With a strategic vision, modern technology foundation, and talented workforce, GENTIS continues to develop a comprehensive genetic ecosystem with outstanding services such as family testing, non-invasive prenatal testing (NIPT), pre-marital and prenatal genetic counseling, and other genetic tests.
GENTIS’s growth is not only a corporate achievement but also a source of pride for Vietnamese medicine in its integration with global trends in personalized healthcare.
15 years – A journey of trust, value, and leadership
For GENTIS, this is just the beginning of an even brighter journey ahead. Once again, congratulations to GENTIS on its 15th anniversary! Wishing the company continued growth and to remain a trusted companion for millions of Vietnamese families in caring for and protecting health through genetic science.
[content_more] => [meta_title] => GENTIS – 15 years of creating value for public health [meta_description] => On the evening of October 25, 2025, in the beautiful coastal city of Ha Long, GENTIS Genetic Analysis Services Joint Stock Company (GENTIS) solemnly held its 15th Anniversary Celebration (October 26, 2010 – October 26, 2025) in a warm, heartfelt, and high [meta_keyword] => [thumbnail_alt] => [post_id] => 1375 [category_id] => 14 ) [6] => stdClass Object ( [id] => 1374 [id_crawler] => [category_product] => NULL [thumbnail] => 565146852_1222653929882222_4756649354324039800_n_(1).jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-10-28 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-28 08:27:20 [updated_time] => 2025-10-28 10:10:27 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-honored-to-welcome-CAP-expert-delegation-at-headquarters-Hanoi [title] => GENTIS honored to welcome CAP expert delegation at headquarters - Hanoi [description] => On October 17, 2025, GENTIS had the honor of welcoming a delegation of senior experts from the College of American Pathologists (CAP) – the world’s leading organization in clinical laboratory accreditation – to visit and work at its headquarters in Hanoi. [content] =>This visit marks a significant milestone, underscoring the strong and enduring partnership between GENTIS and CAP in maintaining and advancing international quality standards for laboratory testing in Vietnam. It also provided an opportunity for both parties to engage in in-depth discussions on sustainable development strategies and future cooperation directions, contributing to the growth of Vietnam’s genetic testing industry to regional and global levels.
The CAP delegation included senior leaders with extensive experience in laboratory science and international market development. Among them were Ms. Xiaocong (Angra) Wang, Regional Leader for Southeast Asia, South Asia, and Oceania; Ms. Elizabeth Tudor, Senior Leader in Global Support and Development; Mr. Sean Harrington, Director of International Market Development; and Mr. Brian Nowlin, Vice President of International Market Development at CAP. The participation of these distinguished experts brought valuable insights, strategic perspectives, and collaboration opportunities for advancing testing standards in Vietnam.

During the working session, the CAP delegation and GENTIS leadership, along with its technical team, exchanged knowledge and international experience in laboratory quality management. They also shared strategic perspectives on developing efficient operational models aimed at transparency and standardization in accordance with CAP standards. The delegation directly visited the PGT and NIPT laboratories, both of which achieved CAP accreditation in June 2025—an important milestone affirming GENTIS’s commitment to quality and credibility.
The College of American Pathologists (CAP) is one of the most prestigious organizations in the world for medical laboratory accreditation and inspection, recognized in over 100 countries. Achieving CAP accreditation means that a laboratory meets the most stringent requirements for operational processes, personnel competence, and test result accuracy. Therefore, GENTIS’s attainment of this certification is not only a source of pride but also clear evidence of its continuous efforts to ensure world-class service quality.
During the visit, the CAP delegation highly commended GENTIS for its investment in modern equipment, strict adherence to quality management procedures, and development of a highly qualified workforce. GENTIS’s achievements in implementing CAP standards reaffirm its professional expertise and pioneering position in the field of genetic testing.
GENTIS is committed to providing laboratory testing services that are accurate, safe, and transparent. Its continuous efforts to maintain, strengthen, and expand international standards such as CAP demonstrate GENTIS’s strong commitment to quality and sustainable development.

The visit and working session with the CAP delegation not only recognized GENTIS’s accomplishments but also opened new avenues for potential collaboration in the future. With a solid foundation of expertise, technology, and human resources, GENTIS continues to affirm its leading position in genetic testing in Vietnam and contributes to the advancement of modern medicine in the region.
[content_more] => [meta_title] => GENTIS honored to welcome CAP expert delegation at headquarters - Hanoi [meta_description] => On October 17, 2025, GENTIS had the honor of welcoming a delegation of senior experts from the College of American Pathologists (CAP) – the world’s leading organization in clinical laboratory accreditation – to visit and work at its headquarters in Hanoi. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1374 [category_id] => 14 ) [7] => stdClass Object ( [id] => 1373 [id_crawler] => [category_product] => NULL [thumbnail] => 565773600_1223544959793119_2949476054075220034_n.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2025-10-27 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2025-10-27 16:45:28 [updated_time] => 2025-10-28 10:38:29 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-welcomes-CAMMED-Medical-Laboratory-for-a-visit-and-collaboration-expanding-international-cooporation-for-public-health [title] => GENTIS welcomes CAMMED Medical Laboratory for a visit and collaboration – expanding international cooperation for public health [description] => On October 18, 2025, at its headquarters in Hanoi, GENTIS Genetic Analysis Services Joint Stock Company proudly welcomed a delegation from CAMMED Medical Laboratory (Cambodia) for a visit and collaborative discussions. The visit marked an important milestone in GENTIS’s international cooperation journey, aiming to bring advanced genetic testing technologies closer to communities across Southeast Asia. [content] =>The CAMMED delegation included members of the Board of Directors, laboratory management, and the business department, led by Ms. Koem Sivfin – Business Director. On the GENTIS side, Mr. Nguyen Manh Ha – CEO, Mr. Pham Dinh Minh – R&D Director, and Ms. Hang Le – International Cooperation Coordinator, attended the meeting.

During the session, GENTIS representatives provided an overview of the company’s operations, professional capabilities, internationally accredited laboratory systems, and advanced genetic testing technologies such as PGT and NIPT.
The CAMMED delegation expressed deep admiration for GENTIS’s modern facilities, rigorous quality control processes, and highly experienced team of experts. Both sides discussed trends in the regional genetic testing industry, shared operational experiences, and explored potential cooperation in training, technology transfer, and applied research.
One key topic of discussion was the plan to expand NIPT services in Cambodia. Drawing from successful implementation in Vietnam, GENTIS shared operational models, professional workflows, and quality assurance standards, enabling CAMMED to develop effective and sustainable prenatal screening services in Cambodia.
Additionally, GENTIS introduced its PGT service – preimplantation genetic testing, an advanced reproductive solution that helps select healthy embryos before in vitro fertilization (IVF). This service is expected to be implemented soon by CAMMED, providing opportunities for many families facing infertility.
The CAMMED delegation also toured GENTIS’s state-of-the-art laboratories and met partner clinics in Hanoi, learning about the connection model between GENTIS and domestic healthcare facilities – an essential foundation for applying this model in the Cambodian market.

The meeting took place in a friendly, professional, and open atmosphere. Both sides affirmed that cooperation between GENTIS and CAMMED goes beyond business interests, reflecting a shared commitment to providing accurate, safe, and humane genetic testing solutions for the benefit of public health in Southeast Asia.
Ms. Koem Sivfin of CAMMED expressed sincere gratitude for GENTIS’s warm reception and expressed confidence that both sides would soon implement multiple concrete collaborative projects.
The visit and working session of CAMMED Medical Laboratory affirmed GENTIS’s prestige, expertise, and influence in the field of genetic testing in Vietnam and the region. It provides an important foundation for GENTIS to continue expanding international cooperation and, together with regional partners, to spread the value of advanced medical science and technology, aiming for comprehensive and sustainable public health care.
[content_more] => [meta_title] => GENTIS welcomes CAMMED Medical Laboratory for a visit and collaboration – expanding international co [meta_description] => On October 18, 2025, at its headquarters in Hanoi, GENTIS Genetic Analysis Services Joint Stock Company proudly welcomed a delegation from CAMMED Medical Laboratory (Cambodia) for a visit and collaborative discussions. [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1373 [category_id] => 14 ) )